Safety and Efficacy of Intranasal Administration of Avacc 10 Vaccine Against COVID-19 in Healthy Volunteers
Clinical trial NCT05604690 · COMPLETED
Trial details
- NCT number
- NCT05604690
- Sponsor
- Intravacc B.V.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-11-03
- Primary completion
- 2023-08-09
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.